Salomon & Ludwin’s Bio-Path Holdings Inc BPTH Stock Holding History

Salomon & Ludwin’s Portfolio BPTH Stock Details BPTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-26	Closed	-$7K	–	229
2019 Q2	$7K	Buy	+26	New	+$8.24K	﹤0.01%	180

Other funds holding BPTH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Salomon & Ludwin's BPTH Position: Q3 2019 in Review

Salomon & Ludwin sold out of Bio-Path Holdings Inc (BPTH) in Q3 2019, closing a stake of 26 shares — an estimated $7K sold.

Salomon & Ludwin first reported a position in BPTH in Q2 2019 and held it in 1 quarter. The position peaked at $7K in Q2 2019. 15 funds tracked by Wall St. Rank hold BPTH as of Q3 2019.

Salomon & Ludwin reported no remaining Bio-Path Holdings Inc position as of Q3 2019 after selling out during the quarter.
Salomon & Ludwin sold 26 Bio-Path Holdings Inc shares in Q3 2019, an estimated $7K.
Salomon & Ludwin first reported a position in Bio-Path Holdings Inc in Q2 2019 and held it in 1 quarter.
Salomon & Ludwin's Bio-Path Holdings Inc position peaked at $7K in Q2 2019.
15 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q3 2019.

Based on Salomon & Ludwin's 13F filing for Q3 2019, filed 6 Nov 2019.